80 Years of vision: preventing blindness from retinopathy of prematurity

Edward H Wood1,2, Emmanuel Y Chang3, Kinley Beck4

  • 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, USA.

Insights

Retinopathy of prematurity (ROP) is a major cause of childhood blindness. This review offers practical guidance on observation and treatment to reduce ROP incidence and improve outcomes for Type 1 ROP.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of preventable childhood blindness globally.
  • Early detection and intervention are crucial for managing ROP and preventing vision loss.

Purpose of the Study:

  • To present a practical framework for the observation and treatment of ROP.
  • To reduce the overall incidence of any ROP.
  • To enhance short-term and long-term outcomes for infants with Type 1 ROP.

Main Methods:

  • This is a review article, synthesizing current knowledge and best practices.
  • The focus is on providing a template for clinical management.
  • Evidence-based guidelines for observation and treatment are discussed.

Main Results:

  • The review outlines key criteria for ROP screening and surveillance.
  • It details treatment strategies for different stages of ROP, particularly Type 1 ROP.
  • The aim is to provide actionable steps for clinicians.

Conclusions:

  • Implementing standardized observational and treatment protocols can decrease ROP prevalence.
  • Improved management strategies lead to better visual outcomes for affected children.
  • A practical template aids in consistent and effective ROP care.